Detalhe da pesquisa
1.
Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging.
Neuroscience
; 133(1): 315-26, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15893653
2.
Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats: an update.
Psychopharmacology (Berl)
; 180(1): 57-62, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15650841
3.
Effect of haloperidol and (-)-sulpiride on dopamine agonist-induced hypoactivity.
Neuropharmacology
; 34(4): 449-55, 1995 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-7566477
4.
Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats.
Neuropharmacology
; 26(7A): 789-92, 1987 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-3627386
5.
Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.
Neuropharmacology
; 29(7): 619-24, 1990 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-2385332
6.
Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine.
Neuropharmacology
; 25(9): 1067-9, 1986 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-3774129
7.
High affinity binding of [3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine.
Neuropharmacology
; 27(3): 235-41, 1988 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-3374769
8.
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors.
Neuropharmacology
; 36(6): 787-92, 1997 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-9225306
9.
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.
Neuropharmacology
; 41(2): 186-99, 2001 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11489455
10.
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat.
J Med Chem
; 43(9): 1878-85, 2000 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-10794704
11.
Localization of serotonin-4 receptors in the striatonigral pathway in rat brain.
Neuroscience
; 69(4): 1159-67, 1995 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-8848104
12.
Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment.
Neuroscience
; 105(2): 353-64, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11672603
13.
Locomotor activity in rats after administration of nicotinic agonists intracerebrally.
Br J Pharmacol
; 99(2): 273-8, 1990 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-2328395
14.
Nicotine cue in rats: effects of central administration of ganglion-blocking drugs.
Br J Pharmacol
; 90(1): 239-46, 1987 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-2880625
15.
Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
Br J Pharmacol
; 126(3): 572-4, 1999 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-10188965
16.
Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways.
Biochem Pharmacol
; 32(5): 865-70, 1983 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-6301501
17.
Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
Biochem Pharmacol
; 33(11): 1747-52, 1984 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-6610420
18.
Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats.
Psychopharmacology (Berl)
; 156(2-3): 327-37, 2001 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-11549233
19.
Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats.
Psychopharmacology (Berl)
; 102(4): 521-8, 1990.
Artigo
em Inglês
| MEDLINE | ID: mdl-2096409
20.
Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats.
Psychopharmacology (Berl)
; 97(3): 295-302, 1989.
Artigo
em Inglês
| MEDLINE | ID: mdl-2497478